NZ594102A - Sustained release of nutrients in vivo - Google Patents

Sustained release of nutrients in vivo

Info

Publication number
NZ594102A
NZ594102A NZ594102A NZ59410209A NZ594102A NZ 594102 A NZ594102 A NZ 594102A NZ 594102 A NZ594102 A NZ 594102A NZ 59410209 A NZ59410209 A NZ 59410209A NZ 594102 A NZ594102 A NZ 594102A
Authority
NZ
New Zealand
Prior art keywords
nutritional supplements
vivo
compounds
release
hydrogel particles
Prior art date
Application number
NZ594102A
Other languages
English (en)
Inventor
Sitaraman Krishnan
Venkat Kalyan Vendra
Frederick A Sexton
Original Assignee
New World Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/087104 external-priority patent/WO2009079537A1/en
Application filed by New World Pharmaceuticals Llc filed Critical New World Pharmaceuticals Llc
Priority to NZ61471009A priority Critical patent/NZ614710A/en
Publication of NZ594102A publication Critical patent/NZ594102A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/272—Gellan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ594102A 2008-12-17 2009-12-17 Sustained release of nutrients in vivo NZ594102A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ61471009A NZ614710A (en) 2008-12-17 2009-12-17 Sustained release of nutrients in vivo

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2008/087104 WO2009079537A1 (en) 2007-12-17 2008-12-17 Sustained release of nutrients in vivo
US12/337,022 US8563066B2 (en) 2007-12-17 2008-12-17 Sustained release of nutrients in vivo
PCT/US2009/068608 WO2010080557A1 (en) 2008-12-17 2009-12-17 Sustained release of nutrients in vivo

Publications (1)

Publication Number Publication Date
NZ594102A true NZ594102A (en) 2013-09-27

Family

ID=42316829

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ594102A NZ594102A (en) 2008-12-17 2009-12-17 Sustained release of nutrients in vivo
NZ61471009A NZ614710A (en) 2008-12-17 2009-12-17 Sustained release of nutrients in vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ61471009A NZ614710A (en) 2008-12-17 2009-12-17 Sustained release of nutrients in vivo

Country Status (13)

Country Link
US (4) US8563066B2 (enExample)
EP (1) EP2389075B1 (enExample)
JP (2) JP6062632B2 (enExample)
KR (1) KR101791836B1 (enExample)
CN (1) CN102316752B (enExample)
AU (1) AU2009335743B2 (enExample)
BR (1) BRPI0922989A8 (enExample)
CA (1) CA2747659C (enExample)
DK (1) DK2389075T3 (enExample)
IL (1) IL213637B (enExample)
MX (1) MX2011006519A (enExample)
NZ (2) NZ594102A (enExample)
WO (1) WO2010080557A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283338B2 (en) 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
US8338389B2 (en) 2009-06-17 2012-12-25 Kao Corporation Agent for preventing or ameliorating obesity
US20110091606A1 (en) * 2009-09-23 2011-04-21 Todd Ehrlich Dietary Supplements in Beverages or Other Forms, and Methods of Use and Production
US20110123672A1 (en) * 2009-11-23 2011-05-26 Xiaohu Xia Gum bases, chewing gums based thereupon, and methods for making the same
MX346257B (es) * 2009-11-23 2017-03-13 Wrigley W M Jun Co Bases de goma, gomas de mascar basadas en las mismas y métodos para hacerlas.
US20170238576A9 (en) * 2009-11-23 2017-08-24 Xiaohu Xia Gum bases containing non-uniform crosslinked polymer microparticles
MY162175A (en) * 2010-09-13 2017-05-31 Bev-Rx Inc Aqueous drug delivery system
EP2645991B1 (en) 2010-12-02 2020-02-12 GreenMark Biomedical Inc. Aptamer bioconjugate drug delivery device
EP2750662A4 (en) 2011-08-31 2015-06-24 Univ Georgia NANOPARTICLES OBTAINING APOPTOSIS
JP6356614B2 (ja) 2012-02-17 2018-07-11 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド 薬剤のミトコンドリア輸送のためのナノ粒子
PL221351B1 (pl) * 2012-03-14 2016-03-31 Politechnika Warszawska Sposób otrzymywania nanocząstek polisacharydowych
ES2596284T3 (es) * 2012-06-27 2017-01-05 Dsm Ip Assets B.V. Nanogel que comprende principios activos hidrosolubles
DE102012108840A1 (de) * 2012-09-20 2014-03-20 Pm-International Ag Sportgetränk mit Algenpulver
CA2906594C (en) 2013-03-15 2019-01-08 Leading Edge Innovations, LLC Substantially surfactant-free, submicron dispersions of hydrophobic agents containing high levels of water miscible solvent
US20140322428A1 (en) 2013-03-15 2014-10-30 Leading Edge Innovations, LLC Compositions having an oil-in-water dispersion of submicron particles to enhance foods and beverages
US9182420B2 (en) * 2013-03-15 2015-11-10 Palo Alto Research Center Incorporated Phase-change enabled flow field visualization
CN103224472B (zh) * 2013-04-07 2015-03-25 许昌学院 一种重金属捕集剂的制备方法
WO2015095185A1 (en) * 2013-12-16 2015-06-25 Massachusetts Institute Of Technology Fortified micronutrient salt formulations
WO2015138992A1 (en) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate
US20170202789A1 (en) 2014-07-16 2017-07-20 New World Pharmaceuticals, Llc Methods and related compositions for improved drug bioavailability and disease treatment
EP3011952A1 (en) * 2014-10-24 2016-04-27 Centre National De La Recherche Scientifique -Cnrs- Time-controlled glucose releasing hydrogels and applications thereof
PL3865563T3 (pl) 2014-11-25 2024-01-29 Corning Incorporated Materiały i sposoby do przedłużania pożywki do hodowli komórkowej
CN104397708A (zh) * 2014-12-17 2015-03-11 周伟成 一种牛大力丸子
CA2969860A1 (en) * 2015-01-07 2016-07-14 Corr-Jensen Inc. Compositions and methods for enhancing athletic performance
ES2846848T3 (es) 2015-10-26 2021-07-29 Harvard College Polisacáridos reducidos y oxidados y métodos de uso de los mismos
AU2016378574C1 (en) * 2015-12-22 2021-12-16 Mccormick & Company, Incorporated High integrity encapsulation product
US10905649B2 (en) * 2016-04-12 2021-02-02 Capsular Technologies Pty Ltd Injectable composition for delivery of a biologically active agent
ES2902450T3 (es) * 2016-04-29 2022-03-28 Laminaria Group Ab Suplementos nutricionales
ES2902697T3 (es) * 2016-04-29 2022-03-29 Laminaria Group Ab Suplementos nutricionales
WO2019161362A1 (en) 2018-02-19 2019-08-22 Abbott Laboratories Lipid emulsion nutritional product
CN112203528A (zh) 2018-03-27 2021-01-08 莱米纳瑞集团公司 营养补充剂
EP3773751A4 (en) 2018-03-28 2021-12-01 GreenMark Biomedical Inc. PHOSPHATE CROSS-LINKED STARCH NANOPARTICLE AND DENTAL TREATMENTS
US11344593B1 (en) 2019-08-19 2022-05-31 Michael Anderson CBD/THC/terpene consistent formulas
CN110859306A (zh) * 2019-12-03 2020-03-06 东北农业大学 一种水凝胶珠的制备方法
US20210244063A1 (en) * 2020-02-06 2021-08-12 Shane Matthew Parker Pre-workout Effervescent Tablet
WO2021222369A1 (en) * 2020-05-01 2021-11-04 Hercules Llc Modified release pharmaceutical formulation comprising hydroxypropyl cellulose
US20220046958A1 (en) * 2020-08-14 2022-02-17 Abt Health And Wellness Private Limited Fortified beverage composition and process of preparing thereof
US12409111B2 (en) 2020-10-27 2025-09-09 Leading Edge Innovations, LLC System, method, and composition for skin improvement and transient flora reduction
WO2023287997A1 (en) * 2021-07-14 2023-01-19 Holy Mary Llc Ilex paraguariensis extracts, compositions, and related methods
US11433381B1 (en) 2021-09-10 2022-09-06 King Abdulaziz University Efficient catalysts for hydrogen production
CN115192541B (zh) * 2022-07-12 2023-10-13 广东省农业科学院蚕业与农产品加工研究所 一种栀子黄色素微胶囊及其制备方法和应用
US12065612B1 (en) 2023-07-27 2024-08-20 Saudi Arabian Oil Company Bistable system for the controlled release of corrosion inhibitors

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2684924A (en) 1951-02-05 1954-07-27 Ici Ltd Nu-chlorophenyldiguanidino compounds
US2990425A (en) 1956-06-06 1961-06-27 Ici Ltd New biguanide salts
BE612529A (enExample) 1961-01-13
US3351583A (en) 1964-07-06 1967-11-07 Hercules Inc Preparation of hydroxypropyl cellulose
DE1492034A1 (de) 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
US3468898A (en) 1966-05-26 1969-09-23 Sterling Drug Inc Bridged bis-biguanides and bis-guanidines
US4022834A (en) 1972-03-16 1977-05-10 A/S Farmaceutisk Industri Antibacterially active hexamethylene-bis-biguanides
US4053636A (en) 1976-05-24 1977-10-11 Sterling Drug Inc. Dichlorocyclopropylphenyl bisbiguanide compounds, processes and compositions
JPS53147073A (en) 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4857331A (en) 1988-03-31 1989-08-15 Warner-Lambert Company Sugarless pectin delivery system
JPH03168359A (ja) 1989-11-24 1991-07-22 Japan Electron Control Syst Co Ltd 内燃機関の点火時期制御装置
US20040195710A1 (en) * 1990-10-15 2004-10-07 Hubbell Jeffrey A. Gels for encapsulation of biological materials
US5484610A (en) * 1991-01-02 1996-01-16 Macromed, Inc. pH and temperature sensitive terpolymers for oral drug delivery
JPH0515317A (ja) * 1991-07-09 1993-01-26 Asahi Chem Ind Co Ltd 微粒子ハイドロゲルの製造方法
JP3591848B2 (ja) 1992-08-05 2004-11-24 住友電気工業株式会社 チュ−ブ
US5360614A (en) 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
JPH07255436A (ja) * 1994-03-25 1995-10-09 Kiteii:Kk 複合飲料
IT1273094B (it) 1994-03-30 1997-07-04 Gilardini Spa Plancia porta-strumenti per autoveicoli con visualizzatore video a scomparsa
US5840338A (en) 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
EP0811056B1 (en) 1995-02-23 2000-05-31 Quest International B.V. Peptides for tissue and cell culture media
JPH0995440A (ja) * 1995-09-29 1997-04-08 Roussel Morishita Kk 徐放性製剤およびその製造方法
US5795606A (en) 1995-10-02 1998-08-18 Hercules Incorporated Method for preparing a coated food
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6018033A (en) 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
US6426086B1 (en) * 1998-02-03 2002-07-30 The Regents Of The University Of California pH-sensitive, serum-stable liposomes
DE69913892T2 (de) * 1998-07-22 2004-12-09 Nippon Paint Co., Ltd. Propargyl in Acetylidform enthaltende Harzzusammensetzung für kationische Elektrotauchlackierung
CA2248592A1 (en) * 1998-08-31 2000-02-29 Christopher D. Batich Microspheres for use in the treatment of cancer
AU1908500A (en) 1998-11-30 2000-06-19 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
AU760508B2 (en) 1999-01-25 2003-05-15 Ecosynthetix Inc. Biopolymer nanoparticles
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
IL157791A0 (en) 2001-03-26 2004-03-28 Nestle Sa Beverage powder
BR0209162B1 (pt) 2001-04-26 2011-07-12 método para preparar um amido reticulado.
WO2003022910A1 (en) * 2001-09-08 2003-03-20 Access Pharmaceuticals, Inc. Synthesis and uses of polymer gel nanoparticle networks
US20030077378A1 (en) 2001-10-22 2003-04-24 Lou Wen Chin Hydroxypropyl cellulose encapsulation material
WO2003082316A1 (en) * 2002-03-29 2003-10-09 The Regents Of The University Of California Microgel particles for the delivery of bioactive materials
US7897384B2 (en) * 2003-09-08 2011-03-01 Ethicon, Inc. Chondrocyte therapeutic delivery system
GB0329907D0 (en) 2003-12-23 2004-01-28 Innomed Ltd Compositions
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
EP1758557B1 (en) * 2004-05-11 2011-07-13 Egalet Ltd. Swellable dosage form comprising gellan gum
SE0402084D0 (sv) 2004-08-26 2004-08-26 Metcon Medicin Ab Method and composition for long-term glycemic control
US7329419B2 (en) * 2004-09-23 2008-02-12 Herbalife International, Inc. Herbal supplement to support weight loss
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US7300365B2 (en) 2005-12-05 2007-11-27 Bradford Carter Taylor Assembly for training hand/eye coordination
US8557274B2 (en) 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
AU2006338273B2 (en) * 2006-02-10 2011-10-13 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
ITPD20060203A1 (it) 2006-05-22 2007-11-23 Univ Degli Studi Trieste Idrogeli di miscele di polisaccaridi per l'ingegneria tissutale e la veicolazione di composti attivi
CN101450996B (zh) 2007-12-07 2011-02-16 北京化工大学 一种葡萄糖响应型聚膦腈水凝胶
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US8518448B2 (en) 2009-06-26 2013-08-27 Robert Niichel Sustained release beads and suspensions including the same for sustained delivery of active ingredients

Also Published As

Publication number Publication date
WO2010080557A1 (en) 2010-07-15
US9554586B2 (en) 2017-01-31
JP2012524711A (ja) 2012-10-18
US20140242212A1 (en) 2014-08-28
US9538775B2 (en) 2017-01-10
DK2389075T3 (en) 2018-02-05
NZ614710A (en) 2015-03-27
US20140037830A1 (en) 2014-02-06
IL213637A0 (en) 2011-07-31
IL213637B (en) 2018-07-31
JP6062632B2 (ja) 2017-01-18
US8563066B2 (en) 2013-10-22
CN102316752A (zh) 2012-01-11
BRPI0922989A2 (pt) 2015-08-11
KR20110135918A (ko) 2011-12-20
US20090155409A1 (en) 2009-06-18
CA2747659C (en) 2017-05-23
CA2747659A1 (en) 2010-07-15
EP2389075B1 (en) 2017-11-15
MX2011006519A (es) 2011-09-22
US20120015039A1 (en) 2012-01-19
EP2389075A1 (en) 2011-11-30
BRPI0922989A8 (pt) 2017-05-23
KR101791836B1 (ko) 2017-10-31
AU2009335743B2 (en) 2015-10-01
HK1165962A1 (en) 2012-10-19
JP2016144448A (ja) 2016-08-12
CN102316752B (zh) 2014-12-24
AU2009335743A1 (en) 2011-08-11

Similar Documents

Publication Publication Date Title
NZ594102A (en) Sustained release of nutrients in vivo
MX2010009852A (es) Microencapsulacion.
Fakhrullin et al. Hybrid cellular− inorganic core− shell microparticles: Encapsulation of individual living cells in calcium carbonate microshells
PL2352386T3 (pl) Sposób wytwarzania związku kwasu n-masłowego w postaci mikrokapsułkowanej do spożycia przez zwierzęta lub ludzi
MY175316A (en) Protection of microbial cells from acidic degradation
BR112012008626A2 (pt) forma farmacêutica oral sólida com liberação modificada de pelo menos um ingrediente ativo
DK2162016T3 (da) Tyggegummigranuler til komprimattyggegummi
MX2008012564A (es) Metodo para preparar microcapsulas por coacervacion.
MY161453A (en) Sealant compositions and methods utilizing nano-particles
CA2455971A1 (en) Encapsulated agglomeration of microcapsules and method for the preparation thereof
UA96342C2 (en) Microspheres having core/shell structure
MX338891B (es) Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.
WO2009069751A1 (ja) 抗菌性人工毛髪及び人工毛髪用抗菌性コーティング剤
WO2010117199A3 (ko) 코엔자임 q10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
WO2008048469A3 (en) Controlled-release coated dosage forms containing galantamine
WO2009001710A1 (ja) 球状銅微粉及びその製造方法
MX2010004962A (es) Mezclas homogeneas y estables en almacenamiento de diferentes particulas de granulos de agentes activos protectores de plantas.
Li et al. Chitosan-Based Hydrogel Beads: Developments, Applications, and Challenges
ATE500726T1 (de) Tierstreu und herstellungsverfahren dafür
WO2007082155A3 (en) Molecules with complexing groups for aqueous nanoparticle dispersions and uses thereof
WO2008021800A3 (en) Method for preventing crystallization
WO2008039052A8 (es) Proceso para estabilización de famotidina
BR112012006267A2 (pt) processo para produzir partículas de substrato orgânico ligadas a nanopartículas ferromagnéticas comutáveis, partículas de substrato para diagnóstico, uso de nanopartículas ferromagnéticas comutáveis, e, medicamento para o tratamento de hipertermia no corpo humano ou animal
MY160667A (en) Granulated aromatic plant products and method for making the same
GB2476425A (en) Gold nanoparticle,a composition and a method to perpetuate stemness thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 17 DEC 2016 BY FB RICE

Effective date: 20140107

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2017 BY COMPUTER PACKAGES INC

Effective date: 20161220

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2018 BY COMPUTER PACKAGES INC

Effective date: 20171201

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2019 BY COMPUTER PACKAGES INC

Effective date: 20181201

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2020 BY COMPUTER PACKAGES INC

Effective date: 20200603

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2021 BY COMPUTER PACKAGES INC

Effective date: 20201218

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 DEC 2022 BY COMPUTER PACKAGES INC

Effective date: 20211217

LAPS Patent lapsed